全文获取类型
收费全文 | 195395篇 |
免费 | 9337篇 |
国内免费 | 2157篇 |
专业分类
耳鼻咽喉 | 3196篇 |
儿科学 | 6690篇 |
妇产科学 | 4711篇 |
基础医学 | 27056篇 |
口腔科学 | 5227篇 |
临床医学 | 16096篇 |
内科学 | 34941篇 |
皮肤病学 | 4880篇 |
神经病学 | 17173篇 |
特种医学 | 9655篇 |
外国民族医学 | 45篇 |
外科学 | 30785篇 |
综合类 | 5170篇 |
现状与发展 | 5篇 |
一般理论 | 38篇 |
预防医学 | 9843篇 |
眼科学 | 5204篇 |
药学 | 14413篇 |
23篇 | |
中国医学 | 1750篇 |
肿瘤学 | 9988篇 |
出版年
2023年 | 1188篇 |
2022年 | 1196篇 |
2021年 | 2690篇 |
2020年 | 2195篇 |
2019年 | 2228篇 |
2018年 | 3818篇 |
2017年 | 3264篇 |
2016年 | 4076篇 |
2015年 | 4876篇 |
2014年 | 5257篇 |
2013年 | 6683篇 |
2012年 | 10231篇 |
2011年 | 9846篇 |
2010年 | 5809篇 |
2009年 | 4629篇 |
2008年 | 9001篇 |
2007年 | 9752篇 |
2006年 | 9804篇 |
2005年 | 10194篇 |
2004年 | 9388篇 |
2003年 | 9120篇 |
2002年 | 8998篇 |
2001年 | 6728篇 |
2000年 | 6845篇 |
1999年 | 6087篇 |
1998年 | 1980篇 |
1997年 | 1690篇 |
1996年 | 1292篇 |
1995年 | 1069篇 |
1994年 | 940篇 |
1993年 | 848篇 |
1992年 | 2612篇 |
1991年 | 2493篇 |
1990年 | 2429篇 |
1989年 | 2272篇 |
1988年 | 1983篇 |
1987年 | 1964篇 |
1986年 | 1812篇 |
1985年 | 1735篇 |
1984年 | 1324篇 |
1983年 | 1054篇 |
1979年 | 1393篇 |
1978年 | 1021篇 |
1977年 | 855篇 |
1975年 | 1084篇 |
1974年 | 1123篇 |
1973年 | 1016篇 |
1972年 | 1026篇 |
1971年 | 1006篇 |
1970年 | 894篇 |
排序方式: 共有10000条查询结果,搜索用时 421 毫秒
71.
Irmak Karaca Suzan Güven Yılmaz Melis Palamar Halil Ateş 《Ocular immunology and inflammation》2020,28(6):947-951
ABSTRACT
Purpose
To investigate the effect of 1% tropicamide on anterior chamber aqueous flare (ACAF) measurements acquired with laser flare meter in patients with pseudoexfoliation. 相似文献72.
目的观察益气活血化瘀方治疗高血压性脑基底节出血术后的临床疗效。方法将60例高血压性脑基底节出血患者随机分为观察组28例与对照组32例,对照组予单纯手术治疗,观察组在手术基础上联合益气活血化瘀方治疗。观察两组患者在治疗前后格拉斯哥昏迷指数(GCS)评分、肌力、血肿体积、中医证候积分、住院时间,并评估疗效。结果经治疗后,两组患者GCS评分明显下降,血肿体积明显缩小,中医证候积分明显降低,术后瘫痪侧肌力均明显改善(均P<0.05),观察组改善程度优于对照组(P<0.05);观察组中医证候总有效率为75.00%,明显高于对照组的59.38%(P<0.05);观察组的住院时间明显短于对照组(P<0.05)。结论益气活血化瘀方联合手术治疗可明显改善高血压性脑基底节出血患者的GCS评分、肌力,降低中医证候积分,缩小血肿体积,缩短住院时间,提高中医证候疗效。 相似文献
73.
74.
75.
76.
控便功能是指当产生便意时,可以辨别粪便干稀急缓,并能正常控制其排出的能力.因一些意外因素,如盆底功能障碍、某些先天性疾病及盆腔恶性肿瘤术后会导致此功能受损,而严重影响患者的生活质量.近年来,诸多国内外学者对控便功能障碍患者进行了临床和影像学研究,能够认知控便功能受损的造成因素及改善方法,对于术前术后制定治疗方案具有重要的临床价值,是目前研究的焦点.以MRI从影像学角度为阐述其障碍发生的可能机制及改善预后提供一定依据.因此,笔者对近年来控便功能障碍的MRI研究进展做简要综述. 相似文献
77.
78.
Julie A. Schmidt Georgina K. Fensom Sabina Rinaldi Augustin Scalbert Paul N. Appleby David Achaintre Audrey Gicquiau Marc J. Gunter Pietro Ferrari Rudolf Kaaks Tilman Kühn Heiner Boeing Antonia Trichopoulou Anna Karakatsani Eleni Peppa Domenico Palli Sabina Sieri Rosario Tumino Bas Bueno-de-Mesquita Antonio Agudo Maria-Jose Sánchez María-Dolores Chirlaque Eva Ardanaz Nerea Larrañaga Aurora Perez-Cornago Nada Assi Elio Riboli Konstantinos K. Tsilidis Timothy J. Key Ruth C. Travis 《International journal of cancer. Journal international du cancer》2020,146(3):720-730
Metabolomics may reveal novel insights into the etiology of prostate cancer, for which few risk factors are established. We investigated the association between patterns in baseline plasma metabolite profile and subsequent prostate cancer risk, using data from 3,057 matched case–control sets from the European Prospective Investigation into Cancer and Nutrition (EPIC). We measured 119 metabolite concentrations in plasma samples, collected on average 9.4 years before diagnosis, by mass spectrometry (AbsoluteIDQ p180 Kit, Biocrates Life Sciences AG). Metabolite patterns were identified using treelet transform, a statistical method for identification of groups of correlated metabolites. Associations of metabolite patterns with prostate cancer risk (OR1SD) were estimated by conditional logistic regression. Supplementary analyses were conducted for metabolite patterns derived using principal component analysis and for individual metabolites. Men with metabolite profiles characterized by higher concentrations of either phosphatidylcholines or hydroxysphingomyelins (OR1SD = 0.77, 95% confidence interval 0.66–0.89), acylcarnitines C18:1 and C18:2, glutamate, ornithine and taurine (OR1SD = 0.72, 0.57–0.90), or lysophosphatidylcholines (OR1SD = 0.81, 0.69–0.95) had lower risk of advanced stage prostate cancer at diagnosis, with no evidence of heterogeneity by follow-up time. Similar associations were observed for the two former patterns with aggressive disease risk (the more aggressive subset of advanced stage), while the latter pattern was inversely related to risk of prostate cancer death (OR1SD = 0.77, 0.61–0.96). No associations were observed for prostate cancer overall or less aggressive tumor subtypes. In conclusion, metabolite patterns may be related to lower risk of more aggressive prostate tumors and prostate cancer death, and might be relevant to etiology of advanced stage prostate cancer. 相似文献
79.
Theresa M. Thole Joern Toedling Annika Sprüssel Sebastian Pfeil Larissa Savelyeva David Capper Clemens Messerschmidt Dieter Beule Stefanie Groeneveld-Krentz Cornelia Eckert Guido Gambara Anton G. Henssen Sabine Finkler Johannes H. Schulte Anja Sieber Nils Bluethgen Christian R. A. Regenbrecht Annette Künkele Marco Lodrini Angelika Eggert Hedwig E. Deubzer 《International journal of cancer. Journal international du cancer》2020,146(4):1031-1041
Accurate modeling of intratumor heterogeneity presents a bottleneck against drug testing. Flexibility in a preclinical platform is also desirable to support assessment of different endpoints. We established the model system, OHC-NB1, from a bone marrow metastasis from a patient diagnosed with MYCN-amplified neuroblastoma and performed whole-exome sequencing on the source metastasis and the different models and passages during model development (monolayer cell line, 3D spheroid culture and subcutaneous xenograft tumors propagated in mice). OHC-NB1 harbors a MYCN amplification in double minutes, 1p deletion, 17q gain and diploid karyotype, which persisted in all models. A total of 80–540 single-nucleotide variants (SNVs) was detected in each sample, and comparisons between the source metastasis and models identified 34 of 80 somatic SNVs to be propagated in the models. Clonal reconstruction using the combined copy number and SNV data revealed marked clonal heterogeneity in the originating metastasis, with four clones being reflected in the model systems. The set of OHC-NB1 models represents 43% of somatic SNVs and 23% of the cellularity in the originating metastasis with varying clonal compositions, indicating that heterogeneity is partially preserved in our model system. 相似文献
80.
目前我国的体医融合已探索出以医院为平台的医院健康指导中心模式、以健身场所为平台的体育俱乐部健康指导模式、以社区为平台的健康监测中心模式和以体医融合健康产业为平台的产学研合作模式等4种运行模式。但总体来说我国体医融合尚处于起步阶段,优化体医融合专门人才培养模式成为体医深度融合发展的关键。研究表明,我国体医融合人才现行培养模式主要以在职培训为主,存在专门人才缺失严重、认证体系有待完善和人才培养模式单一等现实困境。同时提出加强顶层设计夯实体医融合人才培养体系,精心布局优化体医融合人才培养课程体系,强化引导完善体医融合舆论宣传体系,标准引领健全体医融合职业标准等优化路径,以期实现体医融合专门人才队伍的科学化和可持续化发展。 相似文献